MULTIGENT BENZODIAZEPINES REAGENT KIT
Mexico·Clase I·III. DIAGNOSTIC AGENTS·ABBOTT LABORATORIES DE MÉXICO, S.A. DE C.V.·Registered November 27, 2019EL ENSAYO MULTIGENT BENZODIAZEPINES SE UTILIZA PARA LA DETERMINACIÓN CUALITATIVA Y SEMICUANTITATIVA DE LA BENZODIACEPINA EN ORINA HUMANA CON LOS ARCHITECT CSYSTEMS. AGENTE DE DIAGNÓS
THE MULTIGENT BENZODIAZEPINES ASSAY IS USED FOR THE QUALITATIVE AND SEMIQUANTITATIVE DETERMINATION OF BENZODIAZEPINE IN HUMAN URINE WITH ARCHITECT CSYSTEMS. DIAGNOSTIC AGENT
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- REACTIVOS PARA LA DETERMINACIÓN DE LA BENZODIACEPINA EN ORINA HUMANA.
- Trade Name (English)
- REAGENTS FOR THE DETERMINATION OF BENZODIAZEPINE IN HUMAN URINE.
- Analysis ID
- 2193R2019 SSA
- Registration Date
- November 27, 2019
- Name (Spanish)
- ABBOTT LABORATORIES DE MÉXICO, S.A. DE C.V.
- Name (English)
- ABBOTT LABORATORIES DE MÉXICO, S.A. DE C.V.
Access comprehensive regulatory information for MULTIGENT BENZODIAZEPINES REAGENT KIT (MULTIGENT BENZODIAZEPINES REAGENT KIT) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 2193R2019 SSA and manufactured by ABBOTT LABORATORIES DE MÉXICO, S.A. DE C.V.. The device was registered on November 27, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.